Drugs / LC-Z300-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06847178 | Mar → Oct 2025 overdue | type 2 diabetes mellitus | Shanghai Changzheng Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LC-Z300-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06847178 ↗ |
| Known as | Bamboo cane polysaccharide | “The aim of the trial is to investigate the efficacy and safety of an Bamboo cane polysaccharide (oral LC-Z300-01) in subjects with type 2 diabetes.” NCT06847178 ↗ |
| Route | Oral | “oral LC-Z300-01” NCT06847178 ↗ |